CORDIS
EU research results

CORDIS

English EN
Mammography with molecular imaging

Mammography with molecular imaging

Objective

The proposed project focuses on the development of a PET prototype dedicated to the examination of breast cancer, using a gamma ray sensor based on an innovative design and the new generation of photo-detectors and scintillating crystals. The innovative features of the PEMT (Positron Emission MammoTomography) system we propose will imply a high resolution (pushed to the physical limit), higher sensitivity and lower costs. It includes integrated analog and digital electronics through the design of an ASIC chip.
The main application will be early breast cancer diagnosis and evaluation of chemotherapy response. New radio-tracer molecules will be searched for the detection and visualization of the pharmacokinetics of breast tumours, more specific than glucose (FDG) for breast cancer, and based on human amino and fatty acids. Phase I Clinical trials will be performed with the new radio-tracers. A clinical multi-centric validation will be performed for the PEMT prototypes.

Coordinator

CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS

Address

Serrano 117
Madrid

Spain

Administrative Contact

José Mª BENLLOCH (Dr)

Participants (7)

Sort alphabetically

Expand all

TECHNISCHE UNIVERSITÄT MÜNCHEN

Germany

GENERAL EQUIPMENT FOR MEDICAL IMAGING, S. A.

Spain

FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E. V.

Germany

DIGIUTOPIKA LTD

Portugal

C-RAD IMAGING AB

Sweden

KAROLINSKA INSTITUTET

Sweden

NETHERLANDS CANCER INSTITUTE

Netherlands

Project information

Grant agreement ID: 37555

  • Start date

    1 January 2007

  • End date

    31 December 2010

Funded under:

FP6-LIFESCIHEALTH

  • Overall budget:

    € 4 092 804

  • EU contribution

    € 2 500 000

Coordinated by:

CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS

Spain